Down the Rabbit Hole: Reviewing the Evidence for Primary Prevention of Cardiovascular Disease in People with Obesity.
Matheo Augusto Morandi StumpfCintia CercatoMaria Edna de MeloRaul Dias Dos Santos FilhoMarcio Corrêa ManciniPublished in: European journal of preventive cardiology (2023)
Obesity is a prevalent chronic disorder and a well-known risk factor for cardiovascular disease. However, the evidence of treating obesity for primary prevention of major cardiovascular events is still scarce and controversial. In this review, we provided a comprehensive description of the current evidence in treating obesity regarding cardiovascular protection. Bariatric surgery appears to be the most robust method to reduce events in people without established cardiovascular disease. High compliance to lifestyle interventions can further reduce cardiovascular risk. Concerning pharmacological therapies, a post-hoc analysis from SUSTAIN-6 and a meta-analysis from STEP trials suggest that semaglutide, a GLP-1 receptor agonist, could reduce cardiovascular events in people without established cardiovascular disease. The first study addressed specifically a high-risk population with diabetes and, the second, low or intermediary-risk individuals without diabetes. Tirzepatide, a novel dual GIP/GLP-1 agonist, although not yet tested in specific cardiovascular outcomes trials, could be an alternative since it induces loss in weight similar to the achieved by bariatric surgery. Therefore, extrapolated data in distinct baseline cardiovascular risk populations suggest that these two drugs could be used in primary prevention with the aim of preventing cardiovascular events, but the grade of this evidence is still low. Specifically designed studies are needed to address this specific topic.
Keyphrases
- cardiovascular events
- cardiovascular disease
- weight loss
- bariatric surgery
- type diabetes
- insulin resistance
- metabolic syndrome
- weight gain
- high fat diet induced
- obese patients
- cardiovascular risk factors
- coronary artery disease
- glycemic control
- physical activity
- body mass index
- skeletal muscle
- adipose tissue
- machine learning
- big data
- perovskite solar cells